Softgel Capsules Market: Growth, Trends, Segmentation, and Outlook intro The global Softgel Capsules Market is experiencing steady growth as pharmaceutical companies and nutraceutical manufacturers increasingly adopt convenient oral dosage forms. Softgel capsules feature a soft, sealed shell containing liquid, oil-based, or semi-solid formulations. They are widely used for vitamins, dietary supplements, prescription medicines, and over-the-counter products because they are easy to swallow and suitable for delivering various active ingredients. According to Fortune Business Insights, the global Softgel Capsules Market was valued at USD 7.87 billion in 2025. The market is projected to grow from USD 8.32 billion in 2026 to USD 13.46 billion by 2034, exhibiting a compound annual growth rate (CAGR) of 6.20% during the forecast period. Increasing interest in preventive healthcare, rising supplement consumption, and advancements in pharmaceutical formulations are expected to contribute to market expansion.
Growing Demand for Dietary Supplements and Nutraceuticals Increasing consumer awareness of health and wellness is an important factor driving the Softgel Capsules Market. Consumers are showing interest in vitamins, minerals, omega-3 fatty acids, and other nutritional supplements to support their health goals. Softgel capsules provide a convenient format for delivering oil-based ingredients and fat-soluble vitamins. The growing popularity of preventive healthcare is encouraging supplement manufacturers to expand their product portfolios. Softgel formulations can also help protect certain ingredients from environmental exposure when appropriately designed and packaged. These characteristics make them a useful option for manufacturers serving the expanding nutraceutical industry.
Rising Pharmaceutical Applications The pharmaceutical industry represents another important source of demand for softgel capsules. These dosage forms can accommodate specific liquid and lipid-based formulations and may improve the delivery of certain poorly water-soluble active ingredients. Their smooth shells can also make them easier for some patients to swallow than conventional solid dosage forms. Pharmaceutical manufacturers are exploring formulation technologies that support product stability, consistent dosing, and patient convenience. Softgel capsules are used in selected prescription medicines and over-the-counter products, including certain pain relief, digestive health, and specialty formulations. However, the suitability of softgel technology depends on the drug's chemical properties, compatibility with the capsule shell, and manufacturing requirements.
For Detailed Market Insights Fortune Business Insights market report: https://www.fortunebusinessinsights.com/softgel-capsules-market-103353
Type Analysis: Gelatin and Non-Animal Softgel Capsules Based on type, the Softgel Capsules Market is segmented into gelatin capsules and non-animal softgel capsules.
Softgel Capsules Market
Page 1
Gelatin Softgel Capsules: Gelatin-based capsules remain an established option because of their flexibility, sealing properties, and suitability for many pharmaceutical and nutraceutical formulations. Their widespread manufacturing infrastructure supports their use across multiple applications. Non-Animal Softgel Capsules: Non-animal alternatives made using materials such as starches and pullulan are gaining attention among consumers and manufacturers seeking alternatives to animal-derived gelatin. These products may appeal to vegetarian consumers and brands targeting specific dietary preferences. Developments in capsule-shell materials and manufacturing processes are expected to influence competition between these segments. Manufacturers must balance formulation compatibility, stability, production efficiency, and consumer requirements when selecting materials.
Application Analysis The Softgel Capsules Market serves prescription medicines, over-the-counter products, and nutraceutical applications. Prescription medicines use softgel technology for selected formulations requiring specialized delivery characteristics. Over-the-counter products use softgels in categories such as pain management, digestive health, and other consumer healthcare applications. Nutraceuticals represent an important application area because softgels are suitable for many oils, vitamins, and nutritional ingredients. Continued interest in wellness products and convenient supplement formats may support demand across this segment.
Regional Analysis North America dominated the Softgel Capsules Market, accounting for 35.58% of the global market share in 2025. Established pharmaceutical companies, widespread dietary supplement consumption, advanced manufacturing capabilities, and strong demand for wellness products support the region's leading position. Europe benefits from established pharmaceutical manufacturing, healthcare infrastructure, and demand for nutritional supplements. Research into alternative capsule materials and specialized formulations may create additional opportunities. Asia Pacific offers growth potential through expanding pharmaceutical production, increasing healthcare expenditure, and rising consumer awareness of dietary supplements. The region's manufacturing capabilities may also support investment in capsule production and contract manufacturing services. Latin America presents opportunities as access to healthcare products improves and demand for vitamins and nutritional supplements increases. Market development will depend on purchasing power, distribution networks, and manufacturing investment. The Middle East & Africa may experience gradual growth as healthcare infrastructure develops and pharmaceutical distribution expands. Increasing access to consumer healthcare products could support demand for softgel formulations.
Competitive Landscape Competition in the Softgel Capsules Market is shaped by manufacturing capacity, formulation expertise, product quality, technological innovation, and regulatory compliance. Established companies are investing in production capabilities and research to address changing pharmaceutical and nutraceutical requirements. Key companies operating in the market include:
Softgel Capsules Market
Page 2
• Lonza • Sirio Pharma • Catalent Inc. • Hunan Er Kang Pharmaceutical Co., Ltd. • Robinson Pharma
Recent Industry Developments Manufacturing expansion and formulation innovation are important developments in the softgel industry. In June 2025, Robinson Pharma expanded its manufacturing capabilities, including additional production capacity for softgels, capsules, tablets, and liquid products. Such investments reflect efforts to meet demand from pharmaceutical and supplement customers. The industry is also exploring plant-based capsule materials and technologies designed to improve the delivery of selected active ingredients. These developments may help manufacturers respond to changing dietary preferences and increasingly specialized formulation requirements.
Get a Free Sample PDF https://www.fortunebusinessinsights.com/enquiry/request-sample-pdf/softgel-capsules-market-103353
Future Outlook The global Softgel Capsules Market is expected to maintain steady growth through 2034 as pharmaceutical and nutraceutical companies continue to develop convenient and specialized oral dosage forms. According to Fortune Business Insights, the market is projected to increase from USD 8.32 billion in 2026 to USD 13.46 billion by 2034, registering a CAGR of 6.20%. Future growth opportunities will depend on rising supplement consumption, pharmaceutical innovation, improvements in manufacturing processes, and the development of non-animal capsule materials. Companies that prioritize product quality, formulation compatibility, and efficient production may be better positioned to respond to evolving market requirements. Overall, softgel capsules are expected to remain an important dosage format across pharmaceutical, over-the-counter, and nutraceutical applications.
Softgel Capsules Market
Page 3